Long-Term Management of Prolactinomas—Use of Long-Acting Dopamine Agonists

By Cook David  

Reviews in Endocrine and Metabolic Disorders, Vol. 6, Iss. 1, 2005-01 ,pp. : 15-21

Springer Publishing Company

Access to resources Recommend Favorite

Effect of dopaminergic drug treatment on surgical findings in prolactinomas

By Menucci Maria  

Pituitary, Vol. 14, Iss. 1, 2011-03 ,pp. : 68-74

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Pituitary Tumors: Dopamine Agonists

By Iván Gabriella   Szigeti-Csúcs Nikoletta   Oláh Márk   Nagy György M.   Góth Miklós I.  

Endocrine Journal, Vol. 28, Iss. 1, 2005-10 ,pp. : 101-110

Humana Press, Inc

Access to resources Recommend Favorite

Surgical outcomes and risk factors for postoperative complications in patients with Behcet’s disease

By Park Min-Chan   Hong Bum-Kee   Kwon Hyuck   Hong You-Sun  

Clinical Rheumatology, Vol. 26, Iss. 9, 2007-09 ,pp. : 1475-1480

Springer Publishing Company

Access to resources Recommend Favorite

Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas

By Mon Sann   Alkabbani Abdulrahman   Hamrahian Amir   Thorton Julie   Kennedy Lawrence   Weil Robert   Olansky Leann   Doshi Krupa   Makin Vinne   Hatipoglu Betul  

Pituitary, Vol. 16, Iss. 4, 2013-12 ,pp. : 523-527

Springer Publishing Company

Access to resources Recommend Favorite